SARS-CoV-2-specific ELISA development
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 484-485, 112832
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- COVID-19, SARS and MERS: are they closely related?Clinical Microbiology and Infection, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaJAMA, 2020
- Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging virusesMicrobes and Infection, 2020
- Identification of Coronavirus Isolated from a Patient in Korea with COVID-19Osong Public Health and Research Perspectives, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral EpitopeCell Host & Microbe, 2019
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- Cellular entry of the SARS coronavirusTrends in Microbiology, 2004
- A previously undescribed coronavirus associated with respiratory disease in humansProceedings of the National Academy of Sciences, 2004